Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 16,918 shares of the business’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $24.67, for a total transaction of $417,367.06. Following the sale, the insider owned 83,511 shares of the company’s stock, valued at approximately $2,060,216.37. This represents a 16.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Campbell Rogers also recently made the following trade(s):
- On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total transaction of $668,756.57.
- On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $609,623.40.
- On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $46.39, for a total value of $563,963.23.
- On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $1,122,081.32.
- On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33.
- On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total transaction of $987,052.30.
Heartflow Stock Performance
Shares of NASDAQ:HTFL opened at $44.63 on Friday. The firm has a market cap of $3.92 billion, a price-to-earnings ratio of -48.51 and a beta of 2.50. The firm has a fifty day moving average price of $51.82 and a 200 day moving average price of $35.55. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $60.65.
Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.15. The company had revenue of $72.86 million for the quarter. Heartflow had a negative net margin of 33.11% and a negative return on equity of 20.53%. During the same quarter in the prior year, the firm posted ($0.27) earnings per share. As a group, research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.
Recent Heartflow Headlines
Here are a few of the latest headlines about HTFL:
- Negative Sentiment: Filings reported two November 17 sales totaling 36,345 shares at an average of $46.39, alongside another sale of 12,157 shares on October 22 at $55.01. The disclosures also describe additional sales earlier in the year. Repeated insider selling can weigh on sentiment, though the sales were conducted under a pre-arranged plan. SEC Form 4 filing
Institutional Investors Weigh In On Heartflow
Large investors have recently modified their holdings of the business. XXEC Inc. acquired a new position in shares of Heartflow during the second quarter valued at about $2,524,764,000. BlackRock Inc. acquired a new stake in Heartflow in the 2nd quarter worth approximately $152,502,000. Bamco Inc. NY acquired a new stake in Heartflow in the 2nd quarter worth approximately $94,625,000. Jupiter Topco LLC purchased a new stake in Heartflow during the 2nd quarter worth approximately $70,983,000. Finally, Janus Henderson Group PLC grew its position in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after purchasing an additional 1,315,416 shares during the last quarter.
Analyst Upgrades and Downgrades
A number of research firms recently commented on HTFL. Morgan Stanley boosted their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. Wall Street Zen raised Heartflow from a “hold” rating to a “buy” rating in a research note on Sunday, November 15th. Stifel Nicolaus increased their target price on Heartflow from $45.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, November 13th. Robert W. Baird raised their target price on shares of Heartflow from $56.00 to $68.00 and gave the company an “outperform” rating in a report on Friday, November 13th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $60.12.
View Our Latest Research Report on Heartflow
About Heartflow
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Read More
- Five stocks we like better than Heartflow
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
